Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 1,259.92 Billion |
| USD 2,419.80 Billion | |
| % | |
|
Global Continuous Renal Replacement Therapy Market, By Product Type (Dialysates and Replacement Fluids, Disposables, Systems), Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF), Age Group (Adults, Pediatrics /Neonates), End-User (Hospitals, Ambulatory Centers, Specially Clinics, Others) – Industry Trends and Forecast to 2030.
According to a study conducted on 100 critically ill patients in a prospective observational study published in the Journal of Clinical and Diagnostic Research (JCDR) in 2018, In India, AKI was observed in 17.3 cases/1,000 persons. To capitalize on the significant growth opportunities in emerging markets, players are increasingly focusing on strategic developments that will increase their presence in these markets and allow them to reach a large number of customers. Furthermore, due to less stringent data requirements, regulatory policies in the Asia-Pacific region are more adaptable and business-friendly. This, combined with increased competition in mature markets (Europe, Japan, and Australia), will encourage CRRT product manufacturers to concentrate on the emerging market.
Data Bridge Market Research analyses that the continuous renal replacement therapy market which is USD 1259.92 million in 2022, is expected to reach USD 2419.80 million by 2030, at a CAGR of 8.5% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Dialysates and Replacement Fluids, Disposables, Systems), Modality (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF), Age Group (Adults, Pediatrics /Neonates), End-User (Hospitals, Ambulatory Centers, Specially Clinics, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Fresenius Medical Care AG & Co. KGaA (Germany), Baxter (U.S.), B. Braun SE (Germany), Medtronic (Ireland), NxStage Medical, Inc. (U.S.), Nikkiso Co., Ltd. (Japan), Asahi Kasei Corporation (Japan), TORAY MEDICAL CO. LTD. (Japan), Infomed SA (Switzerland), Medica S.p.A. (Italy), Medical Components, Inc. (U.S.), Medites Pharma spol. s.r.o (Czechia), Ningbo Tianyi Medical Devices Co., Ltd (China), cytosorbents (U.S.), BIOMEDICA (Austria), Anjue Medical Equipment Co., Ltd. (China), NIPRO (Japan)
|
|
Market Opportunities
|
|
Market Definition
Continuous renal replacement therapy (CRRT) is a common treatment for critically ill patients with acute kidney injury, especially hemodynamically unstable patients. Acute kidney injury (AKI) is defined as a temporary decrease in kidney function that results in the accumulation of creatinine, urea, and other waste products. It has been linked to sodium and water retention and the development of metabolic disturbances such as metabolic acidosis and hyperkalemia.
Drivers
The increase in the number of medical applications is driving the continuous renal replacement therapy market. Candidates for CRRT include patients with acute renal failure (ARF) who also have significant comorbidities, such as multiple organ failure or defects in their cardiac and circulatory systems, such as cardiac insufficiency and oedema. In addition to renal failure, CRRT can be used to treat multiple organ failure, acute pancreatitis, fulminant hepatitis, and postoperative liver failure.
Furthermore, the clinical advantages of CRRT over intermittent blood purification techniques will be a major factor influencing the growth of the market for continuous renal replacement therapy. Increasing urbanisation and an ageing population are also driving factors in the growth of the continuous renal replacement therapy market.
One of the major drivers driving the expansion of the continuous expansion renal replacement therapy market is the increased prevalence of chronic kidney disease, which is a key risk factor for diabetes, hypertension, cardiovascular disease, and the inflammatory kidney disease known as glomerulonephritis.
Opportunities
The rising prevalence of diabetes and hypertension raises the risk of developing acute kidney injury (AKI), fuelling the market for continuous renal replacement therapy. According to WHO data published in May 2021, 1.13 billion people worldwide are estimated to suffer from hypertension. The rise in high blood pressure rates is likely to have an impact on patients in low and middle-income countries. Every year, hypertension kills approximately 9.4 million people worldwide. It can harm AKI patients and cause acute renal failure. This factor is driving up demand for CRRT systems. Because of increased effectiveness, technological advances in CRRT systems have resulted in a decrease in mortality rate worldwide. An increase in the geriatric population, which is more susceptible to developing AKI, is expected to rise.
Restraints/Challenges
The growing number of complications associated with CRRT will pose a significant challenge to the market's growth rate. The insertion of a large-bore central venous catheter, which may need to be kept in place for an extended period of time, is required to begin CRRT. Catheter insertion is well-known to cause vascular or visceral injury, bleeding, pneumothorax, hem thorax, and the formation of an arteria-venous fistula. Catheter use for an extended period of time has been linked to venous thrombosis and stenosis.
On the other hand, a scarcity of skilled professionals in developing countries will pose a challenge to the market for continuous renal replacement therapy. Furthermore, an unfavorable reimbursement scenario and a lack of awareness will act as a restraint and further impede the market's growth rate during the forecast period of 2023-2030.
This continuous renal replacement therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the continuous renal replacement therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The high number of COVID-19 patients who develop AKI is expected to drive the market for continuous renal replacement therapy over the forecast period. Prior to COVID-19, CRRT was used to treat about 23,105 AKI patients per year. The need for CRRT appears to be 5 times higher in COVID-19 patients, i.e., 4.9 percent, then in historical populations (0.9 percent). In community cohort datasets, 5%-15% of people hospitalised with COVID-19 required dialysis. Furthermore, in some North American regions, the number of people using CRRT increased by 370 percent over normal levels, increasing demand for the product during the pandemic.
Recent Developments
The continuous renal replacement therapy market is segmented on the basis of type, usage, end-user and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
Modality
Age Group
End-User
The continuous renal replacement therapy market is analysed and market size insights and trends are provided by country, type, usage, end-user and application as referenced above.
The countries covered in the continuous renal replacement therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the continuous renal replacement therapy market because of the rising demand for CRRT procedures in this region. Additionally, advanced innovation in the manufacture of machines and systems will flourish the market's growth rate in this region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to rising technological advancement in this region. In addition, rising healthcare expenditures will boost the market's growth rate in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The continuous renal replacement therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for continuous renal replacement therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the continuous renal replacement therapy market. The data is available for historic period 2011-2021.
The continuous renal replacement therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to continuous renal replacement therapy market.
Some of the major players operating in the continuous renal replacement therapy market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.